Efficient and scalable process for the manufacture of fondaparinux sodium

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8987430
APP PUB NO 20130261291A1
SERIAL NO

13791178

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a process for the synthesis of the Factor Xa anticoagulent Fondaparinux and related compounds. The invention relates, in addition, to efficient and scalable processes for the synthesis of various intermediates useful in the synthesis of Fondaparinux and related compounds.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RELIABLE BIOPHARMACEUTICAL LLCRADNOR CORPORATE CENTER 100 MATSONFORD ROAD BUILDING ONE SUITE 200 RADNOR PA 19087

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ma, Chun Ballwin, US 33 150
Nadji, Sourena Olivette, US 13 82
Ohrr, Kevin K Saint Charles, US 2 4
Patel, Payal Parth Fairview Heights, US 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 24, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00